On September 25, 2017, the FDA and lupus patients came together for a historic patient-focused drug development meeting.
New population-based analyses measure incidence and prevalence of lupus among these fast growing U.S. populations.
This new research program provides $5 million that will greatly expand the number of lupus-specific research studies that can be supported through the DoD.
LupusConnect brings together people impacted by lupus to share experiences and find timeless support.
We're working to ensure that the new funding is directed to research projects that can make the most difference.
A nine-year research study has identified two dozen new genes linked to the autoimmune disease lupus.
Benlysta SC is the first self-injection lupus treatment that can administered at home once per week.
House Appropriations Committee Approves Lupus Research and Education Funding as Senate Continues Debate on Health Reform